The injection of IL-8 inhibitor (MAB208 antibody) in melanoma xenografts suppressed the recruitment of F4/80+ TAMs in a tumor that was associated with a decreased number of CD31+ cells [85]. The gene discussed is CXCL8; the disease is neoplasm.